Author

N. Laham-Karam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

E. Aavik· 1 shared E. Tukiainen· 1 shared H. H. Pulkkinen· 1 shared H. Ilmonen· 1 shared H. Rasinkangas· 1 shared J. Aronniemi· 1 shared J. J. Liikkanen· 1 shared J. Lohi· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

E. Aavik

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ErbB Signalling is a Potential Therapeutic Target for Vascular Lesions with Fibrous Component

H. Ilmonen, S. Jauhiainen, P. Vuola, H. Rasinkangas, H. H. Pulkkinen, S. Keränen, M. Kiema, J. J. Liikkanen, N. Laham-Karam, S. Laidinen, E. Aavik, K. Lappalainen, J. Lohi, J. Aronniemi, T. Örd, , J. P. Laakkonen

This study identifies ErbB signaling as a therapeutic target for vascular lesions with fibrous components by showing TGFA/VEGF-A paracrine signaling and the effect of PIK3CA mutations.

bioRxiv · Sep 23, 2022 · PreprintCell Biology